These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21275492)
21. Evaluation of a pretest scoring system (4Ts) for the diagnosis of heparin-induced thrombocytopenia in a university hospital setting. Vatanparast R; Lantz S; Ward K; Crilley PA; Styler M Postgrad Med; 2012 Nov; 124(6):36-42. PubMed ID: 23322137 [TBL] [Abstract][Full Text] [Related]
22. Evaluating the role for the optical density in the diagnosis of heparin-induced thrombocytopenia following cardiac surgery. Chan CM; Corso PJ; Sun X; Hill PC; Shorr AF Thromb Haemost; 2011 Nov; 106(5):934-8. PubMed ID: 21947303 [TBL] [Abstract][Full Text] [Related]
23. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061 [TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia. Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439 [TBL] [Abstract][Full Text] [Related]
25. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem. Raschke RA; Curry SC; Warkentin TE; Gerkin RD Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622 [TBL] [Abstract][Full Text] [Related]
26. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery. Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. Hanson SJ; Punzalan RC; Ghanayem N; Havens P Pediatr Crit Care Med; 2007 Jul; 8(4):358-61. PubMed ID: 17545932 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993 [TBL] [Abstract][Full Text] [Related]
29. Testing for heparin-induced thrombocytopenia antibodies. Warkentin TE; Sheppard JA Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164 [TBL] [Abstract][Full Text] [Related]
30. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens. Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391 [TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Cuker A Thromb Haemost; 2011 Dec; 106(6):993-4. PubMed ID: 22012630 [No Abstract] [Full Text] [Related]
32. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Lo GK; Sigouin CS; Warkentin TE Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079 [TBL] [Abstract][Full Text] [Related]
33. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289 [TBL] [Abstract][Full Text] [Related]
34. Simple scoring system for early management of heparin-induced thrombocytopenia. Messmore HL; Fabbrini N; Bird ML; Choudhury AM; Cerejo M; Prechel M; Jeske WP; Siddiqui A; Thethi I; Wehrmacher WH; Walenga JM Clin Appl Thromb Hemost; 2011 Apr; 17(2):197-201. PubMed ID: 21159704 [TBL] [Abstract][Full Text] [Related]
35. Can thromboelastography predict which patients with heparin-induced thrombocytopenia may suffer thrombotic complications of type II? Kouerinis IA; El-Ali M; Theakos N; Dedeilias P Eur J Cardiothorac Surg; 2007 Sep; 32(3):544-6. PubMed ID: 17632008 [TBL] [Abstract][Full Text] [Related]
36. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia. Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Refaai MA; Laposata M; Van Cott EM Am J Clin Pathol; 2003 Jan; 119(1):61-5. PubMed ID: 12520698 [TBL] [Abstract][Full Text] [Related]
39. Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study. Galea V; Khaterchi A; Robert F; Gerotziafas G; Hatmi M; Elalamy I Platelets; 2013; 24(6):441-7. PubMed ID: 22994796 [TBL] [Abstract][Full Text] [Related]
40. External validation of the HIT Expert Probability (HEP) score. Joseph L; Gomes MP; Al Solaiman F; St John J; Ozaki A; Raju M; Dhariwal M; Kim ES Thromb Haemost; 2015 Mar; 113(3):633-40. PubMed ID: 25588983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]